Cancer Genetics Names John Pappajohn Chairman of the Board of Directors

Cancer Genetics (Nasdaq: CGIX ) today announced that its board of directors appointed John Pappajohn as its new Chairman, effective January 6, 2014. Mr. Pappajohn is a recognized business leader and a pioneer in the venture capital industry. He has been involved in over 100 start-up companies, over 50 IPOs, and has served as a director